1AI 0.00% 1.0¢ algorae pharmaceuticals limited

Ann: Half Yearly Report and Accounts, page-11

  1. 11,717 Posts.
    lightbulb Created with Sketch. 5937
    The PR and Marketing is going to be instrumental in LCT success as a Treatment Company. They need to start making inroads as the editorial content of what they are completing now will gain a far greater audience than any advertising campaign later. They could attract in excess of 5000 customers from the Editorial content negating the need for costly advertising at a later date. One single mention on CNN, BBC, can drive tens of thousands of potential customers to your website. You can encompass continents with your story.
    You may have been a holder for a long while also, you would have to admit getting any news has been difficult for LCT. I'm saying you have to start somewhere, the transition from Researcher to Commercial Service Provider and attracting paying customer/patients is no walk in the Park.
    All going well Paying Patients in 7 months, not long to get the ducks rowed up to launch a Global Medical Treatment Service Provider.
    Also it would make other potential surgery providers around the world aware of LCT and could begin relationships between the Likes of the Mayo Clinic etc, Surgeons will be able to come to NZ and view the Procedure with LCT providing the Imupel to Hospitals Globally, That could also be one of the reasons we just took on 11 more new staff.
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $16.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $1.3K 130K

Buyers (Bids)

No. Vol. Price($)
7 4791986 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 1107268 8
View Market Depth
Last trade - 10.00am 21/06/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.